Growth hormone and insulin-like growth factor 1 levels and their relation to survival in children with bacterial sepsis and septic shock

Journal of Paediatrics and Child Health

Volumn 40, Issue 4, 2004, Pages 221-226

  Onenli Mungan N ^a   Yildizdas, D ^a   Yapicioglu, H ^a   Topaloglu, A K ^a   Yuksel B ^a   Ozer G ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Children; Growth hormone; Insulin like growth factor 1; Sepsis

Indexed keywords

GROWTH HORMONE; HYDROCORTISONE; INOTROPIC AGENT; SOMATOMEDIN C;

ARTICLE; CHILD; CHILD CARE; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GROWTH HORMONE BLOOD LEVEL; HORMONE METABOLISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SEPSIS; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; SURVIVAL;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; PREGNANCY PROTEINS; PREVALENCE; SEPSIS; SHOCK, SEPTIC; SURVIVORS;

EID: 2342583543     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2004.00342.x     Document Type: Article

References (27)

1. Lawler DA. Hormonal response in sepsis. Crit. Care Nurs. Clin. North Am. 1994; 6: 265-74.
2. Berghe GVD. The neuroendocrine response to stress in a dynamic process. Best Pract. Res. Clin. Endocrinol. Metab. 2001; 15: 405-19.
3. Baxter RC. Changes in the IGF-I/IGFBP axis in critical illness. Best Pract. Res. Clin. Endocrinol. Metab. 2001; 15: 421-34.
4. Inoue T, Saito H, Fukushima R et al. Growth hormone and insulin-like growth factor I enhance host defense, in a murine sepsis model. Arch. Surg. 1995; 130: 1115-22.
5. Unneberg K, Balteskard L, Mjaaland M, Sager G, Revhaug A. Growth hormone increases and IGF-I reduces the response to Escherichia coli infusion in injured pigs. Eur. J. Surg. 1997; 163: 779-88.
6. Lin MT, de Groof F, Joosten KF et al. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between non-survivors and survivors. J. Clin. Endocrinol. Metab. 2002; 87: 3118-24.
7. Rondanelli M, Caselli U, Arico M et al. Insulin-like growth factor I and IGF-binding protein response to growth hormone is impaired in HIV-infected children. AIDS Res. Hum. Retroviruses 2002; 18: 331-9.
8. Saito H, Inoue T, Fukatsu K et al. Growth hormone and the immune response to bacterial infection. Horm. Res. 1996; 45: 50-4.
9. Voerman HJ, Van Schijndel RJ, Groeneveld AB et al. Effects of recombinant human growth hormone in patients with severe sepsis. Ann. Surg. 1992; 4: 648-55.
10. Voerman BJ, Strack van Schijndel RJ, Groenveld AB, de Boer H, Nanta JP, Thijs LD. Effect of human growth hormone in critically ill non-septic patients: results from a prospective, randomized, placebo-controlled trial. Crit. Care Med. 1995; 23: 665-73.
11. Knox J, Demling R, Wilmore D, Sarraf P, Santos A. Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J. Trauma 1995; 39: 526-30.
12. Carroll PV. Treatment with growth hormone and insulin-like growth factor I in critical illness. Clin. Endocrinol. Metab. 2001; 15: 435-53.
13. Balteskard L, Unnegerg K, Mjaaland M, Sager G, Jenssen TG, Revhaug A. Treatment with growth hormone and insulin-like growth factor I in septicemia: effects on carbohydrate metabolism. Eur. Surg. Res. 1998; 30: 79-94.
14. Takala J, Ruokonen E, Webster NR et al. Increased mortality associated with growth hormone treatment in critically adults. N. Engl. J. Med. 1999; 341: 785-92.
15. Hayden WR. Sepsis terminology in pediatrics. J. Pediatr. 1994; 124: 657-8.
16. Drobny EC, Ambum K, Baumann G. Circadian variation of basal plasma growth hormone in man. J. Clin. Endocrinol. Metab. 1983; 57: 524-8.
17. Daughaday WH, Rotwein P. Insulin-like growth factors I and II: peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocrine Rev. 1989; 10: 68-76.
18. Gianotti L, Broglio F, Dimaretti G et al. Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditions. J. Endocrinol. Invest. 1998; 21: 115-21.
19. Van den Berghe G, Baxter RC, Weckers F, Wouters P, Bowers CY, Veldhuis JD. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. J. Clin. Endocrinol. Metab. 2000; 85: 183-92.
20. Elsasser TH, Caperna TJ, Rumsey TS. Endotoxin administration decreases plasma insulin-like growth factor I and IGF-binding protein 2 in Angus x Hereford steers independent of changes in nutritional intake. J. Endocrinol. 1995; 144: 109-17.
21. Beishuizen A, Thijs LG. Relative adrenal failure in intensive care: an identifiable problem requiring treatment. Best Pract. Res. Clin. Endocrinol. Metab. 2001; 15: 513-33.
22. Joosten KFM, Kleijn ED, Westerterp M et al. Endocrine and metabolic responses in children with meningococcal sepsis: striking differences between survivors and nonsurvivors. JCEM 2000; 85: 3746-53.
23. Isley WL, Underwood LE, Clemmons DR. Dietary components that regulate serum somatomedin-C concentrations in humans. J. Clin. Invest. 1983; 71: 175-82.
24. Wojnar MM, Fan J, Li YH et al. Endotoxin-induced changes in IGF-I differ in rats provided enteral vs parenteral nutrition. Am. J. Physiol. 1999; 276: 455-64.
25. Ross R, Miell J, Freeman E et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity with low levels of insulin like growth factor I. Clin. Endocrinol. 1991; 35: 47-54.
26. Voerman HJ, van Schijndel RJ, Groeneveld AB, de Boer H, Nauta JP, Thijs LG. Pulsatile hormone secretion during severe sepsis: accuracy of different blood sampling regimens. Metabolism 1992; 41: 934-9.
27. O'Leary MJ, Quiton N, Ferguson CN, Preedy VR, Ross RJ, Hinds CJ. In rats with sepsis, the acute fall in IGF-I is associated with an increase in circulating growth hormone-binding protein levels. Intensive Care Med. 2000; 26: 1547-52.